Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The aie of this clinical study is the safety and efficacy of combination therapy for HCC patients.
Epistemonikos ID: 276bdfdfe06c399405202fca30e113b40f7d778e
First added on: May 07, 2024